Auris Health, Inc.
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $125k | Debt | |
$34.4m | Series A | ||
$150m | Series B | ||
N/A | $49.0m | Series C | |
$280m Valuation: $1.0b | Series D | ||
$220m | Growth Equity VC | ||
$3.4b Valuation: $3.4b | Acquisition | ||
Total Funding | CAD1b |
Related Content
Recent News about Auris Health, Inc.
EditAuris Health, Inc. is a pioneering company in the medical technology sector, focusing on transforming medical interventions through advanced robotics. The company has developed a cutting-edge platform that leverages flexible robotics to enhance endoscopy procedures. Endoscopy involves using small cameras and tools to navigate the body's natural openings for diagnostic and therapeutic purposes. Auris Health's platform integrates the latest advancements in robotics, micro instrumentation, endoscope design, sensing, and data science to improve patient outcomes and reduce healthcare costs.
The primary market for Auris Health is the medical field, specifically targeting hospitals, clinics, and healthcare providers that perform endoscopic procedures. The company's innovative platform is particularly beneficial for diagnosing and treating lung cancer through robotic-assisted bronchoscopy, a procedure that examines the airways and lungs.
Auris Health operates on a business-to-business (B2B) model, selling its robotic platforms and related services directly to healthcare institutions. The company generates revenue through the sale of its robotic systems, ongoing maintenance contracts, and potentially through data analytics services that help optimize the use of their technology.
In summary, Auris Health is at the forefront of medical robotics, offering a sophisticated platform that enhances the capabilities of endoscopic procedures. By integrating multiple advanced technologies, the company aims to improve patient care and reduce costs for healthcare providers.
Keywords: medical robotics, endoscopy, flexible robotics, lung cancer, bronchoscopy, healthcare technology, micro instrumentation, data science, patient outcomes, cost reduction.